Compare

CJC-1295 vs Ipamorelin

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

810 users report co-tracking this pair (26% of CJC-1295 trackers also track Ipamorelin).

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

CJC-1295

33 community reports

Positive 96% · Neutral 4% · Negative 0%

Most reported benefits

Energy
138
Sleep
138

Most reported side effects

Fatigue
2
Headache
2
Water retention
1

Dose distribution

Median: 400–600 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
0
100–200
24
200–400
39
400–600
23
600–1000
0
1000–2000
31
2000+
21

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 48 days · Based on 25 repeat reporters

Ipamorelin

102 community reports

Positive 98% · Neutral 2% · Negative 0%

Most reported benefits

Energy
236
Sleep
236

Most reported side effects

Water retention
2
Headache
2

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
12
100–200
63
200–400
137
400–600
22
600–1000
0
1000–2000
0
2000+
2

How repeat users are trending

Among repeat reporters, 98% said they felt similar to their last entry, 2% more positive, and 0% more negative.

Overall, repeat reporters leaned similar or mixed compared to their previous entry.

Median gap between entries: 51 days · Based on 44 repeat reporters